ZEB2 and neoplasm: Presumably, tumor cells in patients with low NKX2.2 levels and/or high ZEB2 levels are further along mesenchymal differentiation and may exhibit pronounced migratory characteristics, allowing them to metastasize to distal sites with enhanced capacity.